AVNS
AVNS
NYSE · Health Care

Avanos Medical Inc

$24.93
+0.30 (+1.22%)
As of Jul 4, 10:21 PM ET ·
Financial Highlights (FY 2026)
Revenue
709.50M
Net Income
-73,761,889
Gross Margin
50.5%
Profit Margin
-10.4%
Rev Growth
-5.1%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 50.5% 50.5% 62.5% 62.5%
Operating Margin -8.8% -7.9% 19.2% 18.9%
Profit Margin -10.4% -9.9% 15.7% 17.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 709.50M 747.47M 134.83M 155.65M
Gross Profit 358.08M 377.25M 84.30M 97.32M
Operating Income -62,293,761 -59,064,880 25.89M 29.38M
Net Income -73,761,889 -69,938,579 21.13M 26.73M
Gross Margin 50.5% 50.5% 62.5% 62.5%
Operating Margin -8.8% -7.9% 19.2% 18.9%
Profit Margin -10.4% -9.9% 15.7% 17.2%
Rev Growth -5.1% -5.1% +2.6% +23.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 66.77M 66.77M 313.58M 310.39M
Total Equity 517.19M 517.19M 338.13M 361.58M
D/E Ratio 0.13 0.13 0.93 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -22,969,485 -22,988,844 34.86M 46.09M
Free Cash Flow 16.58M 14.70M